Diploma of Advanced Science (DAS) (Pharmaceutical Medicine ECPM)
2017 - 2019
University of California, Berkeley
Master of Business Administration (M.B.A.) (Business Administration and Management, General)
2016 - 2016
Vlerick Business School
Master of Business Administration (M.B.A.) (Executive MBA)
2014 - 2016
Stellenbosch University/Universiteit Stellenbosch
Master of Business Administration (M.B.A.) (Executive MBA)
2015 - 2015
IFB
Management Pharmaceutical Business Administration
2014 - 2015
Northwestern University - Kellogg School of Management
MBA Marketing,Pricing and New Product Development
2011 - 2012
Nyenrode Business Universiteit
Executive MBA (EMBA)
2011 - 2012
Hospital Herzzentrum Coswig
resident in training cardiothoracic surgery (Medicine)
2006 - 2010
Leiden University
MD (Medicine)
1991 - 1998
Christelijk Gymnasium Sorghvliet
High School
1985 - 1991
Gerald Panday's Skills
New Business Development
Cardiac Surgery
Business Launch
Product Launch
Interventional Cardiology
Medical Education
Healthcare
Hospitals
Surgery
Change Management
Gerald Panday's Summary
Gerald Panday, based in The Hague, ZH, NL, is currently a Ad Interim Global Medical Head Tralokinumab at LEO Pharma, bringing experience from previous roles at LEO Pharma, AstraZeneca, The Janssen Pharmaceutical Companies of Johnson & Johnson and Boehringer Ingelheim. Gerald Panday holds a 2017 - 2019 Diploma of Advanced Science (DAS) in Pharmaceutical Medicine ECPM @ University of Basel. With a robust skill set that includes New Business Development, Cardiac Surgery, Business Launch, Product Launch, Interventional Cardiology and more, Gerald Panday contributes valuable insights to the industry. Gerald Panday has 1 email and 1 mobile phone number on RocketReach.